Construction and Characterization of a Novel Fusion Protein MG7-scFv/SEB against Gastric Cancer
Figure 7
Ten gastric-cancer-bearing rats in each group were subcutaneously injected with same number tumor cells and observed for tumor nodules growth after being administrated with MG7-scFv/SEB, SEB, or NS. More potent inhibition of tumor growth was observed in MG7-scFv/SEB-treated group compared with the other two groups ().